DE69323070T2 - Methandiphosphonsäure-derivat, verfahren zu ihrer herstellung und pharmazeutische verwendung davon - Google Patents
Methandiphosphonsäure-derivat, verfahren zu ihrer herstellung und pharmazeutische verwendung davonInfo
- Publication number
- DE69323070T2 DE69323070T2 DE69323070T DE69323070T DE69323070T2 DE 69323070 T2 DE69323070 T2 DE 69323070T2 DE 69323070 T DE69323070 T DE 69323070T DE 69323070 T DE69323070 T DE 69323070T DE 69323070 T2 DE69323070 T2 DE 69323070T2
- Authority
- DE
- Germany
- Prior art keywords
- production
- acid derivative
- pharmaceutical use
- methandiphosphonic
- methandiphosphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- MBKDYNNUVRNNRF-UHFFFAOYSA-N medronic acid Chemical class OP(O)(=O)CP(O)(O)=O MBKDYNNUVRNNRF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655381—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring
- C07F9/65539—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a seven-(or more) membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
- C07F9/655354—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
- C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4292685A JPH06135976A (ja) | 1992-10-30 | 1992-10-30 | メタンジホスホン酸誘導体、その製造方法およびその医薬用途 |
PCT/JP1993/001579 WO1994010181A1 (fr) | 1992-10-30 | 1993-10-29 | Derive de methanediphosphonate, son procede de production et son utilisation pharmaceutique |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69323070D1 DE69323070D1 (de) | 1999-02-25 |
DE69323070T2 true DE69323070T2 (de) | 1999-05-20 |
Family
ID=17784980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69323070T Expired - Fee Related DE69323070T2 (de) | 1992-10-30 | 1993-10-29 | Methandiphosphonsäure-derivat, verfahren zu ihrer herstellung und pharmazeutische verwendung davon |
Country Status (6)
Country | Link |
---|---|
US (1) | US5565440A (de) |
EP (1) | EP0627438B1 (de) |
JP (1) | JPH06135976A (de) |
CA (1) | CA2127115C (de) |
DE (1) | DE69323070T2 (de) |
WO (1) | WO1994010181A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8257438B2 (en) * | 2005-04-12 | 2012-09-04 | Warsaw Orthopedic, Inc. | Methods and devices for preserving motion in an articulating prosthetic disc |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3203309A1 (de) * | 1982-01-27 | 1983-07-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate |
FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
JPS6366190A (ja) * | 1986-09-05 | 1988-03-24 | Yamanouchi Pharmaceut Co Ltd | ジフエニルアゾ−ルジホスホン酸誘導体 |
JPH0377894A (ja) * | 1989-08-18 | 1991-04-03 | Toray Ind Inc | メチレンジホスホン酸化合物 |
WO1992003451A1 (en) * | 1990-08-21 | 1992-03-05 | The Upjohn Company | Bisphosphonic acid derivatives as anti-arthritic agents |
US5159108A (en) * | 1990-09-18 | 1992-10-27 | Merck & Co., Inc. | Process for preparing an antihypercalcemic agent |
US5204334A (en) * | 1990-10-18 | 1993-04-20 | Ciba-Geigy Corporation | Benzoheterocyclylalkylaminoalkanediphosphonic acids, compositions thereof, and use thereof in the treatment of calcium metabolism disorders |
ATE165603T1 (de) * | 1991-09-05 | 1998-05-15 | Toray Industries | Methandiphosphonsäurederivat, herstellung davon und verwendung davon als arzneimittel |
-
1992
- 1992-10-30 JP JP4292685A patent/JPH06135976A/ja active Pending
-
1993
- 1993-10-29 US US08/256,186 patent/US5565440A/en not_active Expired - Fee Related
- 1993-10-29 DE DE69323070T patent/DE69323070T2/de not_active Expired - Fee Related
- 1993-10-29 EP EP93923673A patent/EP0627438B1/de not_active Expired - Lifetime
- 1993-10-29 WO PCT/JP1993/001579 patent/WO1994010181A1/ja active IP Right Grant
- 1993-10-29 CA CA002127115A patent/CA2127115C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0627438A1 (de) | 1994-12-07 |
DE69323070D1 (de) | 1999-02-25 |
CA2127115A1 (en) | 1994-05-01 |
JPH06135976A (ja) | 1994-05-17 |
EP0627438A4 (de) | 1995-02-01 |
EP0627438B1 (de) | 1999-01-13 |
WO1994010181A1 (fr) | 1994-05-11 |
US5565440A (en) | 1996-10-15 |
CA2127115C (en) | 1997-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59307218D1 (de) | Modifizierte polyasparaginsäuren, verfahren zu ihrer herstellung und ihre verwendung | |
ATE166049T1 (de) | Phthalimidoperoxihexansäure, verfahren zu deren herstellung und deren verwendung | |
DE69210067D1 (de) | Hydraxamsäurederivate, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE69211076T3 (de) | Polyasparaginsäure-zusammensetzung, verfahren zu ihrer herstellung und ihre verwendung | |
ATA125988A (de) | Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung | |
DE58904479D1 (de) | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung. | |
ATE234291T1 (de) | Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung | |
DE58904567D1 (de) | Quinuclidine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung. | |
DE3860503D1 (de) | 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung. | |
ATA312987A (de) | Brenzkatechin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe | |
DE69131627T2 (de) | Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung | |
ATA191889A (de) | Fettsäurezusammensetzung, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung, die sie enthält | |
DE68908374D1 (de) | Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel. | |
DE59007528D1 (de) | Biskationische säureamid- und -imidderivate und verfahren zu ihrer herstellung. | |
DE69332117T2 (de) | 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung | |
ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE69523571T2 (de) | Pyridylimidazol-derivate und verfahren zu ihrer herstellung | |
DE68912944D1 (de) | Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung. | |
DE3674521D1 (de) | 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte. | |
DE59608892D1 (de) | Iminooxyphenylessigsäurederivate, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung | |
DE3682370D1 (de) | 3-aminocarbonyl-1,4-dihydropyridin-5-carboxylsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69527445D1 (de) | Aminooligosaccharid-derivate und verfahren zu ihrer herstellung | |
DE69712361D1 (de) | Erythromycinderivate, verfahren zu ihrer herstellung, und ihrer verwendung als arzneimitteln | |
DE3681701D1 (de) | Chinazolin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung. | |
DE69323070D1 (de) | Methandiphosphonsäure-derivat, verfahren zu ihrer herstellung und pharmazeutische verwendung davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |